Hybrid PET/MRI in Neurodegenerative Disorders.
作者信息
Keir Graham, Li Yi, Chiang Gloria
机构信息
Division of Neuroradiology, Department of Radiology, Weill Cornell Medicine, NewYork-Presbyterian Hospital, 525 East 68th Street, Starr Pavilion, Box 141, New York, NY 10065, USA.
Department of Radiology, Brain Health Imaging Institute, Weill Cornell Medicine, NewYork-Presbyterian Hospital, 407 E 61 st Street, New York, NY 10065, USA.
出版信息
Adv Clin Radiol. 2024 Sep;6(1):121-135. doi: 10.1016/j.yacr.2024.04.013. Epub 2024 Jun 3.
Abstract
摘要
相似文献
1
Hybrid PET/MRI in Neurodegenerative Disorders.神经退行性疾病中的PET/MRI联合成像
Adv Clin Radiol. 2024 Sep;6(1):121-135. doi: 10.1016/j.yacr.2024.04.013. Epub 2024 Jun 3.
2
Integrated Positron Emission Tomography/Magnetic Resonance Imaging in clinical diagnosis of Alzheimer's disease.正电子发射断层扫描/磁共振成像在阿尔茨海默病临床诊断中的应用。
Eur J Radiol. 2021 Dec;145:110017. doi: 10.1016/j.ejrad.2021.110017. Epub 2021 Nov 3.
3
Positron Emission Tomography Molecular Imaging of the Major Neurodegenerative Disorders: Overview and Pictorial Essay, from a Nuclear Medicine Center's Perspective.从核医学中心视角看主要神经退行性疾病的正电子发射断层扫描分子成像：概述与图文综述
J Integr Neurosci. 2023 Dec 13;22(6):172. doi: 10.31083/j.jin2206172.
4
Current Trends and Applications of PET/MRI Hybrid Imaging in Neurodegenerative Diseases and Normal Aging.PET/MRI 融合成像在神经退行性疾病和正常衰老中的当前趋势与应用
Diagnostics (Basel). 2024 Mar 10;14(6):585. doi: 10.3390/diagnostics14060585.
5
The use of positron emission tomography/magnetic resonance imaging in dementia: A literature review.正电子发射断层扫描/磁共振成像在痴呆中的应用：文献综述。
Int J Geriatr Psychiatry. 2021 Oct;36(10):1501-1513. doi: 10.1002/gps.5586. Epub 2021 Jun 12.
6
Comparative Diagnostic Performance of Amyloid-β Positron Emission Tomography and Magnetic Resonance Imaging in Alzheimer's Disease: A Head-to-Head Meta-Analysis.阿尔茨海默病中淀粉样蛋白-β正电子发射断层扫描和磁共振成像的比较诊断性能：一项头对头的荟萃分析。
Brain Behav. 2024 Oct;14(10):e70111. doi: 10.1002/brb3.70111.
7
Hybrid PET-MRI Applications in Movement Disorders.混合 PET-MRI 在运动障碍中的应用。
Int Rev Neurobiol. 2019;144:211-257. doi: 10.1016/bs.irn.2018.10.003. Epub 2018 Nov 8.
8
Multiparametric magnetic resonance imaging and positron emission tomography findings in neurodegenerative diseases: Current status and future directions.多参数磁共振成像和正电子发射断层扫描在神经退行性疾病中的研究进展：现状与未来方向。
Neuroradiol J. 2021 Aug;34(4):263-288. doi: 10.1177/1971400921998968. Epub 2021 Mar 5.
9
Update on the Use of PET/MRI Contrast Agents and Tracers in Brain Oncology: A Systematic Review.脑肿瘤中 PET/MRI 对比剂和示踪剂的应用进展：系统评价。
Int J Nanomedicine. 2022 Jul 29;17:3343-3359. doi: 10.2147/IJN.S362192. eCollection 2022.
10
Elevated tau in the piriform cortex in Alzheimer's but not Parkinson's disease using PET-MR.使用PET-MR检测发现，阿尔茨海默病而非帕金森病患者的梨状皮质中tau蛋白水平升高。
Alzheimers Dement (Amst). 2024 Nov 23;16(4):e70040. doi: 10.1002/dad2.70040. eCollection 2024 Oct-Dec.
引用本文的文献
1
Emerging biomarkers in amyotrophic lateral sclerosis: from pathogenesis to clinical applications.肌萎缩侧索硬化症中的新兴生物标志物：从发病机制到临床应用
Front Mol Biosci. 2025 Jun 30;12:1608853. doi: 10.3389/fmolb.2025.1608853. eCollection 2025.
本文引用的文献
1
Change in Epidemiology of Creutzfeldt-Jakob Disease in the US, 2007-2020.2007 - 2020年美国克雅氏病的流行病学变化
JAMA Neurol. 2024 Feb 1;81(2):195-197. doi: 10.1001/jamaneurol.2023.4678.
2
Plasma Aβ42/Aβ40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease.血浆 Aβ42/Aβ40 和磷酸化 tau217 浓度比值提高了临床前阿尔茨海默病淀粉样 PET 分类的准确性。
Alzheimers Dement. 2024 Feb;20(2):1214-1224. doi: 10.1002/alz.13542. Epub 2023 Nov 6.
3
2023 Alzheimer's disease facts and figures.2023 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2023 Apr;19(4):1598-1695. doi: 10.1002/alz.13016. Epub 2023 Mar 14.
4
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
5
Brain PET Imaging: Approach to Cognitive Impairment and Dementia.脑正电子发射断层扫描成像：认知障碍和痴呆的评估方法。
PET Clin. 2023 Jan;18(1):103-113. doi: 10.1016/j.cpet.2022.09.006.
6
Multimodality Imaging in Primary Progressive Aphasia.原发性进行性失语症的多模态影像学。
AJNR Am J Neuroradiol. 2022 Sep;43(9):1230-1243. doi: 10.3174/ajnr.A7613. Epub 2022 Aug 25.
7
Overview of tau PET molecular imaging.tau蛋白正电子发射断层扫描分子成像概述。
Curr Opin Neurol. 2022 Apr 1;35(2):230-239. doi: 10.1097/WCO.0000000000001035.
8
FDG-PET in presymptomatic C9orf72 mutation carriers.无症状 C9orf72 突变携带者中的 FDG-PET。
Neuroimage Clin. 2021;31:102687. doi: 10.1016/j.nicl.2021.102687. Epub 2021 Apr 25.
9
Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy.评估 18F-PI-2620 作为进行性核上性麻痹的生物标志物。
JAMA Neurol. 2020 Nov 1;77(11):1408-1419. doi: 10.1001/jamaneurol.2020.2526.
10
ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project.主观认知下降中的 ATN 分类和临床进展：SCIENCe 项目。
Neurology. 2020 Jul 7;95(1):e46-e58. doi: 10.1212/WNL.0000000000009724. Epub 2020 Jun 10.
Zotero 插件